Risk Factors and Multiple Interaction Effects for Hyperammonemia in Patients Receiving Valproic Acid
ABSTRACT Background Valproic acid (VPA) use is associated with an increased risk of hyperammonemia (HA); however, the specific interactions between HA risk factors in VPA‐treated patients remain unclear. Objectives This study aimed to identify and assess the effects of multiple interactions between...
Saved in:
Published in | Fundamental & clinical pharmacology Vol. 39; no. 4; pp. e70030 - n/a |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
01.08.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!